Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcuflex
- Development stage
- Unknown
- Lead developer
- Lucky Core Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Alcuflex is a pain management pharmaceutical product developed and marketed by Lucky Core Industries Limited (formerly ICI Pakistan), a Pakistani conglomerate. The active ingredient in Alcuflex is naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID). It works by non-selectively inhibiting the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), which are responsible for the synthesis of prostaglandins that mediate inflammation, pain, and fever. Alcuflex is approved and launched in Pakistan for the management of acute pain and is part of Lucky Core's pharmaceutical portfolio, which includes various products in the pain and gastroenterology therapeutic areas.
- Brand names
- Alcuflex
- Other names
- naproxen sodium
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Alcuflex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alcuflex.